Selective arterial temporary flow arrest with balloons during transvenous embolization for the treatment of brain arteriovenous malformations: a feasibility study with MRI-monitored adverse events.
arteriovenous malformation
balloon
blood flow
intervention
liquid embolic material
Journal
Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
05
08
2021
accepted:
28
11
2021
pubmed:
14
1
2022
medline:
18
11
2022
entrez:
13
1
2022
Statut:
ppublish
Résumé
The technique of endovascular transvenous embolization for brain arteriovenous malformations (AVMs) has emerged in the last 8 years as a very promising therapeutic alternative for otherwise incurable cases. Selective temporary flow arrest during transvenous endovascular embolization (TFATVE) is a novel adaptation of our previously described transvenous approach, which employs hyper-compliant balloons intra-arterially for the selective occlusion of arterial feeders during ethylene vinyl copolymer (EVOH) injection, in order to reduce intra-nidal pressure and increase nidi occlusion rates. We performed a feasibility study of the TFATVE technique between January 2016 and April 2020. Consecutive patients were included. All patients had at least one axial brain MRI or CT in the first 48 hours following intervention, and at least one brain MRI scan within the first postoperative month, in order to detect both silent and clinically evident adverse events. Patients' demographics, angio-architectural characteristics, total injection and procedure times, angiographic and clinical outcomes were analyzed. 22 patients underwent TFATVE during transvenous endovascular treatment of brain AVMs. Among them, 86.4% were high Spetzler-Martin's grade. Good clinical outcome (modified Rankin Scale <2) was achieved in 95.5% of the cases, with 0% of procedure-related mortality and 4.5% of clinically significant, procedure-related morbidity. Total occlusion of the nidus was achieved in >90% of the cases at the end of the procedure and angiographic stability was achieved in all cases; 100% of the cases had angiographic cure at follow-up. TFATVE seems a safe and effective technique when conducted in carefully selected patients in highly specialized centers.
Sections du résumé
BACKGROUND
BACKGROUND
The technique of endovascular transvenous embolization for brain arteriovenous malformations (AVMs) has emerged in the last 8 years as a very promising therapeutic alternative for otherwise incurable cases. Selective temporary flow arrest during transvenous endovascular embolization (TFATVE) is a novel adaptation of our previously described transvenous approach, which employs hyper-compliant balloons intra-arterially for the selective occlusion of arterial feeders during ethylene vinyl copolymer (EVOH) injection, in order to reduce intra-nidal pressure and increase nidi occlusion rates.
METHODS
METHODS
We performed a feasibility study of the TFATVE technique between January 2016 and April 2020. Consecutive patients were included. All patients had at least one axial brain MRI or CT in the first 48 hours following intervention, and at least one brain MRI scan within the first postoperative month, in order to detect both silent and clinically evident adverse events. Patients' demographics, angio-architectural characteristics, total injection and procedure times, angiographic and clinical outcomes were analyzed.
RESULTS
RESULTS
22 patients underwent TFATVE during transvenous endovascular treatment of brain AVMs. Among them, 86.4% were high Spetzler-Martin's grade. Good clinical outcome (modified Rankin Scale <2) was achieved in 95.5% of the cases, with 0% of procedure-related mortality and 4.5% of clinically significant, procedure-related morbidity. Total occlusion of the nidus was achieved in >90% of the cases at the end of the procedure and angiographic stability was achieved in all cases; 100% of the cases had angiographic cure at follow-up.
CONCLUSIONS
CONCLUSIONS
TFATVE seems a safe and effective technique when conducted in carefully selected patients in highly specialized centers.
Identifiants
pubmed: 35022303
pii: neurintsurg-2021-018097
doi: 10.1136/neurintsurg-2021-018097
pmc: PMC9685709
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1234-1238Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Neurosurgery. 1995 Jul;37(1):29-35; discussion 35-6
pubmed: 8587687
Neurosurgery. 2008 Nov;63(5):823-9; discussion 829-31
pubmed: 19005371
Neurosurg Rev. 2019 Mar;42(1):15-22
pubmed: 28735438
J Neurointerv Surg. 2021 Mar;13(3):241-246
pubmed: 32989031
J Neurosurg. 1980 Oct;53(4):456-64
pubmed: 7420165
Acta Neurochir (Wien). 2015 Nov;157(11):1879-86; discussion 1886
pubmed: 26385113
J Neurosurg. 2003 Apr;98(4):747-50
pubmed: 12691399
Neurosurgery. 2016 Mar;78(3):458-65
pubmed: 26457485
J Neurol Neurosurg Psychiatry. 1986 Jan;49(1):1-10
pubmed: 3958721
Neurosurgery. 1999 Apr;44(4):881-6; discussion 886-7
pubmed: 10201317
J Neurointerv Surg. 2021 Jul;13(7):637-641
pubmed: 32900907
Neurosurgery. 2018 Nov 1;83(5):957-964
pubmed: 29281075
Neurosurgery. 1994 Jan;34(1):2-6; discussion 6-7
pubmed: 8121564
Acta Neurochir Suppl. 2010;107:71-6
pubmed: 19953374
Anesthesiology. 2000 Oct;93(4):998-1001
pubmed: 11020753
J Neurosurg. 2015 May;122(5):1229-38
pubmed: 25794338
Stroke. 2009 Jan;40(1):100-5
pubmed: 19008469
J Clin Neurosci. 2002 Jan;9(1):37-40
pubmed: 11749015
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Neurosurgery. 1999 Aug;45(2):351-63; discussion 363-5
pubmed: 10449081
J Neurol Neurosurg Psychiatry. 1998 Oct;65(4):547-54
pubmed: 9771782
Neurology. 2006 May 9;66(9):1350-5
pubmed: 16682666
Neurosurgery. 2013 Sep;73(3):417-29
pubmed: 23728451
J Neurosurg Sci. 2019 Aug;63(4):468-472
pubmed: 29444556
Neurosurgery. 2011 Oct;69(4):815-20; discussion 820-1
pubmed: 21637138
Neurosurgery. 2016 Jan;78(1):34-41
pubmed: 26317676
Neurosurgery. 1985 Mar;16(3):421-30
pubmed: 3885072
AJNR Am J Neuroradiol. 2000 Aug;21(7):1255-67
pubmed: 10954278
J Neurointerv Surg. 2021 Apr;13(4):324-330
pubmed: 33593797